Wood Louise, Martinez Carlos
General Practice Research Database Division, Medicines and Healthcare products Regulatory Agency, London, UK.
Drug Saf. 2004;27(12):871-81. doi: 10.2165/00002018-200427120-00004.
The General Practice Research Database (GPRD) is the world's largest computerised database of anonymised longitudinal clinical records from primary care. The database already has an international reputation in the field of drug safety signal evaluation where the results of GPRD-based pharmacoepidemiological studies have been used to inform regulatory pharmacovigilance decision making. The characteristics and richness of the data are such that the GPRD is likely to prove a key data resource for the proactive pharmacovigilance anticipated in risk management and pharmacovigilance plans. An update of recent developments to the database and new data available from it -- including spontaneously recorded suspected adverse drug reactions -- is presented in the article, with a description of how the data can be used to support a variety of pharmacovigilance applications. The possibility of using the GPRD in signal detection and assessment of the impact of pharmacovigilance activities in the future is also discussed.
全科医疗研究数据库(GPRD)是世界上最大的关于初级保健中匿名纵向临床记录的计算机化数据库。该数据库在药物安全信号评估领域已享有国际声誉,基于GPRD的药物流行病学研究结果已被用于为监管药物警戒决策提供信息。数据的特性和丰富性使得GPRD很可能成为风险管理和药物警戒计划中预期的主动药物警戒的关键数据资源。本文介绍了该数据库的最新发展情况以及可从该数据库获得的新数据——包括自发记录的疑似药物不良反应,并描述了如何利用这些数据支持各种药物警戒应用。还讨论了未来在信号检测以及评估药物警戒活动影响方面使用GPRD的可能性。